Gisela Nogales‐Gadea

Maastricht University — Netherlands

Medicine · Health Sciences

28h-index3.2kcitations96works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glycogen Storage Diseases and Myoclonus(45), Genetic Neurodegenerative Diseases(31), Genetics and Neurodevelopmental Disorders(23), Muscle Physiology and Disorders(20), Neurological disorders and treatments(11)

Publications96 total

HDAC11 deficiency improves muscle phenotype in a Duchenne muscular dystrophy murine model by reducing inflammation and fibrosis
Life Sciences·2025
123PHDAC11 deficiency regulates age-related muscle decline and sarcopenia
Neuromuscular Disorders·2025
16OCalcitriol ameliorates myotonia in 3D DM1 skeletal muscle models via a MBNL1-independent mechanism
Neuromuscular Disorders·2025
385PMitochondrial network alterations in myotonic dystrophy type 1 disease
Neuromuscular Disorders·2025
Characterization of <i>DMPK</i> and MBNL1 expression in cell models of myotonic dystrophy: a platform for drug screening
NAR Molecular Medicine·2025· 1 citedOpen Access
Efficacy of MLN9708 (ixazomib) in experimental autoimmune myasthenia gravis and in anti-AChR producing primary thymic cell cultures from myasthenia gravis patients
Frontiers in Immunology·2025· 2 citedOpen Access
HDAC11 deficiency regulates age-related muscle decline and sarcopenia
GeroScience·2025Open Access
Characterisation of <i>DMPK</i> and MBNL1 expression in cell models of Myotonic Dystrophy: A platform for drug screening
2025
Immortalized human myotonic dystrophy type 1 muscle cell lines to address patient heterogeneity
iScience·2024· 2 citedOpen Access
AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action
Science Advances·2024· 8 citedOpen Access
464P Advancing preclinical research of myotonic dystrophy type 1 with 3D functional human skeletal muscle tissues
Neuromuscular Disorders·2024
Immortalized human myotonic dystrophy type 1 muscle cell lines to address patient heterogeneity
iScience·2024· 8 citedOpen Access
Efficacy of Mln9708 (Ixazomib) in Experimental Autoimmune Myasthenia Gravis and in Anti-Achr Producing Primary Thymic Cell Cultures from Myasthenia Gravis Patients
SSRN Electronic Journal·2024· 1 citedOpen Access
Low aerobic capacity in McArdle disease: A role for mitochondrial network impairment?
Molecular Metabolism·2022· 10 citedOpen Access
Senescence plays a role in myotonic dystrophy type 1
JCI Insight·2022· 22 citedOpen Access
An Integrative Analysis of DNA Methylation Pattern in Myotonic Dystrophy Type 1 Samples Reveals a Distinct DNA Methylation Profile between Tissues and a Novel Muscle-Associated Epigenetic Dysregulation
Biomedicines·2022· 6 citedOpen Access
Identification of Potential Muscle Biomarkers in McArdle Disease: Insights from Muscle Proteome Analysis
International Journal of Molecular Sciences·2022· 2 citedOpen Access
Erratum to ``Clinical practice guidelines for glycogen storage disease V &amp; VII (McArdle disease and Tarui disease) from an international study group'' [Neuromuscular Disorders 31 (2021) 1296–1310]
Neuromuscular Disorders·2022Open Access
Preclinical Research in McArdle Disease: A Review of Research Models and Therapeutic Strategies
Genes·2021· 6 citedOpen Access
Characterization of RAN Translation and Antisense Transcription in Primary Cell Cultures of Patients with Myotonic Dystrophy Type 1
Journal of Clinical Medicine·2021· 13 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Alejandro Lucía(30), Joaquı́n Arenas(25), Antoni L. Andreu(24), Miguel A. Martı́n(23), Tomàs Pinós(15), Alfredo Santalla(9), Carlos Rubio-Terrés(8), Isabel Illa(7), Inés García‐Consuegra(7), Noemí de Luna(7), Carmen Fiuza‐Luces(7), Luís Querol(6), Eduard Gallardo(6), Margarita Pérez(6), María Morán(6), Alfonsina Ballester‐Lopez(6), Guillem Pintos‐Morell(6), J Coll(6), Jordi Díaz‐Manera(5), Ricard Rojas‐García(5)